Scientists at the California National Primate Research Center succeeded in mimicking the early stages of Alzheimer's disease in rhesus monkeys used as a model animal, in a way that could shed light on how the disease begins in humans. The microglia cells in the brains of monkeys injected with soluble fragments of the amyloid beta protein were more highly activated than the cells of the control group. These cells can cause damage to nerve cells. In addition, the levels of biological markers in the brain fluid of the monkeys that received the injections matched those that characterize the early stages of Alzheimer's disease in humans.
Taken from https://fbresearch.org SmartBrief
Translation: Let the Patients Live